SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Parallax Health Sciences, Inc. (PRLX) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PRLX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.05
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2010 |
$-0.12 |
$20.4K |
$-5.13M |
-25150.4% |
| 2011 |
$-0.02 |
$192.25K |
$-1.97M |
-1023.3% |
| 2012 |
$-0.01 |
$0.00 |
$-554.67K |
- |
| 2013 |
$0.00 |
$0.00 |
$-504.49K |
- |
| 2014 |
$-0.01 |
$0.00 |
$-1.11M |
- |
| 2015 |
$-0.03 |
$11.58M |
$-3.42M |
-29.5% |
| 2016 |
$-0.07 |
$23.14M |
$-8.23M |
-35.6% |
| 2017 |
$-0.08 |
$3.2M |
$-13.88M |
-434.3% |
| 2018 |
$0.08 |
$11.74K |
$16.29M |
138762.4% |
| 2019 |
$-0.05 |
$128.6K |
$-12.87M |
-10004.9% |
